AEON Biopharma, Inc. (AEON)

AEON Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2023	FY 2023	FY 2022
Period Ending	Mar 16, 2026	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	16	22	268	-	-	-
Market Cap Growth	1566.35%	-91.93%	-	-	-	-
Enterprise Value	27.65	21.6	262.39	0	0	0
Last Close Price	1.14	38.88	518.40	-	-	-
PE Ratio	-	0.53	11.08	-	-	-
PB Ratio	-	-	-1.25	-	-	-
P/TBV Ratio	-	-	-1.25	-	-	-
P/FCF Ratio	-	-	-272.61	-	-	-
P/OCF Ratio	-	-	-272.61	-	-	-
EV/EBITDA Ratio	-	0.30	-78.90	-	-	-
EV/EBIT Ratio	-	0.30	-78.90	-	-	-
EV/FCF Ratio	-	-	-267.36	-	-	-
Net Debt / Equity Ratio	-	-	0.02	-	-	-
Net Debt / EBITDA Ratio	-	-	1.55	-	-	-
Net Debt / FCF Ratio	-	-	5.26	-	-	-
Quick Ratio	-	-	0.40	-	-	-
Current Ratio	-	-	0.48	-	-	-
Return on Equity (ROE)	-	-54.89%	-13.04%	-	-	76.60%
Return on Assets (ROA)	-	2132.51%	-89.27%	-	-	-4780.11%
Return on Invested Capital (ROIC)	-	-1284.72%	53.78%	-	-	-6453.14%
Return on Capital Employed (ROCE)	-	-2352.84%	107.21%	-	-	6.51%
Earnings Yield	-0.02%	187.58%	9.03%	-	-	-
FCF Yield	-86.31%	0.00%	-0.37%	-	-	-

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q